A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML Other Refereed Contribution to Refereed Journals uri icon

Overview

Published in

  • Leukemia

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2017.84

Additional Document Info

Parent Title

  • LEUKEMIA

Volume

  • 31

Issue

  • 6

Publisher

  • Nature Publishing Group